51P Efficacy and safety by time to maintenance therapy treatment initiation in PRIMA/ENGOT-OV26/GOG-3012

Journal article

Open access

Peer reviewed

C.A. Haslund, L.J. Willmott, M.J. Rubio Pérez, N. Cloven, H.F.M. Van den Bulck, R.G. Moore, C. Pisano, R.E. O'Cearbhaill, F. Selle, B. Pothuri, …

ESMO open, Vol.9, p.103558

06/2024

Files and links (1)

url

https://doi.org/10.1016/j.esmoop.2024.103558View

Published (Version of record) Open

1 Record Views

Title: 51P Efficacy and safety by time to maintenance therapy treatment initiation in PRIMA/ENGOT-OV26/GOG-3012
Creators: C.A. Haslund - Aalborg University Hospital
L.J. Willmott - Arizona Oncology
M.J. Rubio Pérez - Spanish Ovarian Cancer Research Group
N. Cloven - Texas Oncology
H.F.M. Van den Bulck - The European Academy of Gynaecological Surgery
R.G. Moore - University of Rochester
C. Pisano - Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
R.E. O'Cearbhaill - Memorial Sloan Kettering Cancer Center
F. Selle - Groupe Hospitalier Diaconesses Croix Saint-Simon
B. Pothuri - Gynecologic Oncology Group
P. Harter - Kliniken Essen-Mitte
S. Ghamande - Augusta University Health
I. Bruchim - Hillel Yaffe Medical Center
P. Disilvestro - Women & Infants Hospital of Rhode Island
M.P. Barretina Ginesta - Institut d'Investigació Biomèdica de Girona
A. Koliadi - Uppsala University Hospital
I. Malinowska - Medical Development, GSK, Waltham, MA, USA
W. York - Medical Development, GSK, Philadelphia, PA, USA
A. González-Martín - Spanish Ovarian Cancer Research Group
B.J. Monk - Creighton University
Publication Details: ESMO open, Vol.9, p.103558
Publisher: Elsevier Ltd
Identifiers: 991006098553002656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article